{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:03:10Z","timestamp":1781827390069,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T00:00:00Z","timestamp":1512000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T00:00:00Z","timestamp":1512000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>1q21.1 hemizygous microdeletion is a copy number variant leading to eightfold increased risk of schizophrenia. In order to investigate biological alterations induced by this microdeletion, we generated a novel mouse model (<jats:italic>Df(h1q21)\/+)<\/jats:italic>and characterized it in a broad test battery focusing on schizophrenia-related assays.<jats:italic>Df(h1q21)\/+<\/jats:italic>mice displayed increased hyperactivity in response to amphetamine challenge and increased sensitivity to the disruptive effects of amphetamine and phencyclidine hydrochloride (PCP) on prepulse inhibition. Probing of the direct dopamine (DA) pathway using the DA D1 receptor agonist SKF-81297 revealed no differences in induced locomotor activity compared to wild-type mice, but<jats:italic>Df(h1q21)\/+<\/jats:italic>mice showed increased sensitivity to the DA D2 receptor agonist quinpirole and the D1\/D2 agonist apomorphine. Electrophysiological characterization of DA neuron firing in the ventral tegmental area revealed more spontaneously active DA neurons and increased firing variability in<jats:italic>Df(h1q21)\/+<\/jats:italic>mice, and decreased feedback reduction of DA neuron firing in response to amphetamine. In a range of other assays,<jats:italic>Df(h1q21)\/+<\/jats:italic>mice showed no difference from wild-type mice: gross brain morphology and basic functions such as reflexes, ASR, thermal pain sensitivity, and motor performance were unaltered. Similarly, anxiety related measures, baseline prepulse inhibition, and seizure threshold were unaltered. In addition to the central nervous system-related phenotypes,<jats:italic>Df(h1q21)\/+<\/jats:italic>mice exhibited reduced head-to tail length, which is reminiscent of the short stature reported in humans with 1q21.1 deletion. With aspects of both construct and face validity, the<jats:italic>Df(h1q21)\/+<\/jats:italic>model may be used to gain insight into schizophrenia-relevant alterations in dopaminergic transmission.<\/jats:p>","DOI":"10.1038\/s41398-017-0011-8","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T14:35:32Z","timestamp":1511966132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmission"],"prefix":"10.1038","volume":"7","author":[{"given":"Jacob","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Fejgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Sotty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"M\u00f8rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus T.","family":"Christoffersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Yavich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes B.","family":"Lauridsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Egebjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Werge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Kallunki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth V.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Didriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,30]]},"reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/schbul\/sbp006","volume":"35","author":"OD Howes","year":"2009","unstructured":"Howes, O. D. & Kapur, S. The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophr. Bull. 35, 549\u2013562 (2009).","journal-title":"Schizophr. Bull."},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/BF00216006","volume":"91","author":"JA Lieberman","year":"1987","unstructured":"Lieberman, J. A., Kane, J. M. & Alvir, J. Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology 91, 415\u2013433 (1987).","journal-title":"Psychopharmacology"},{"key":"11_CR3","unstructured":"Connell, P. H. Amphetamine Psychosis (Chapman & Hall, London, 1958)."},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","volume":"97","author":"A Abi-Dargham","year":"2000","unstructured":"Abi-Dargham, A. et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Natl Acad. Sci. USA 97, 8104\u20138109 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","volume":"69","author":"OD Howes","year":"2012","unstructured":"Howes, O. D. et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch. Gen. Psychiatry 69, 776\u2013786 (2012).","journal-title":"Arch. Gen. Psychiatry"},{"key":"11_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"S Ripke","year":"2014","unstructured":"Ripke, S. et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421\u2013427 (2014).","journal-title":"Nature"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1192\/bjp.bp.113.132308","volume":"204","author":"J Kambeitz","year":"2014","unstructured":"Kambeitz, J., Abi-Dargham, A., Kapur, S. & Howes, O. D. Alterations in cortical and extrastriatal subcortical dopamine function in schizophrenia: systematic review and meta-analysis of imaging studies. Br. J. Psychiatry 204, 420\u2013429 (2014).","journal-title":"Br. J. Psychiatry"},{"key":"11_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.biopsych.2016.03.2104","volume":"81","author":"JJ Weinstein","year":"2017","unstructured":"Weinstein, J. J. et al. Pathway-specific dopamine abnormalities in schizophrenia. Biol. Psychiatry 81, 31\u201342 (2017).","journal-title":"Biol. Psychiatry"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature07239","volume":"455","author":"JL Stone","year":"2008","unstructured":"Stone, J. L. et al. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455, 237\u2013241 (2008).","journal-title":"Nature"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature07229","volume":"455","author":"H Stefansson","year":"2008","unstructured":"Stefansson, H. et al. Large recurrent microdeletions associated with schizophrenia. Nature 455, 232\u2013236 (2008).","journal-title":"Nature"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1192\/bjp.bp.113.131052","volume":"204","author":"E Rees","year":"2014","unstructured":"Rees, E. et al. Analysis of copy number variations at 15 schizophrenia-associated loci. Br. J. Psychiatry 204, 108\u2013114 (2014).","journal-title":"Br. J. Psychiatry"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ng.3725","volume":"49","author":"C Marshall","year":"2017","unstructured":"Marshall, C. et al. A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects. Nat. Genet. 49, 27\u201335 (2017).","journal-title":"Nat. Genet."},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMoa0805384","volume":"359","author":"HC Mefford","year":"2008","unstructured":"Mefford, H. C. et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N. Engl. J. Med. 359, 1685\u20131699 (2008).","journal-title":"N. Engl. J. Med."},{"key":"11_CR14","first-page":"1","volume":"18","author":"R Bernier","year":"2015","unstructured":"Bernier, R. et al. Clinical phenotype of the recurrent 1q21.1 copy-number variant. Genet. Med. 18, 1\u20139 (2015).","journal-title":"Genet. Med."},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000450971","volume":"7","author":"BF Gamba","year":"2016","unstructured":"Gamba, B. F. et al. Interstitial 1q21.1 microdeletion is associated with severe skeletal anomalies, dysmorphic face and moderate intellectual disability. Mol. Syndromol. 7, 344\u2013348 (2016).","journal-title":"Mol. Syndromol."},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fped.2016.00120","volume":"4","author":"MC Digilio","year":"2016","unstructured":"Digilio, M. C. & Marino, B. What is new in genetics of congenital heart defects? Front. Pediatr. 4, 120 (2016).","journal-title":"Front. Pediatr."},{"key":"11_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.biopsych.2013.07.022","volume":"75","author":"G Kirov","year":"2014","unstructured":"Kirov, G. et al. The penetrance of copy number variations for schizophrenia and developmental delay. Biol. Psychiatry 75, 378\u2013385 (2014).","journal-title":"Biol. Psychiatry"},{"key":"11_CR18","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/nm.4196","volume":"22","author":"MC O\u2019Donovan","year":"2016","unstructured":"O\u2019Donovan, M. C. & Owen, M. J. The implications of the shared genetics of psychiatric disorders. Nat. Med. 22, 1214\u20131219 (2016).","journal-title":"Nat. Med."},{"key":"11_CR19","unstructured":"Paxinos, G., Franklin K. The Mouse Brain in Stereotaxic Coordinates (Academic Press, New york, 2001)."},{"key":"11_CR20","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/j.1471-4159.2009.06004.x","volume":"109","author":"F Sotty","year":"2009","unstructured":"Sotty, F., Montezinho, L. P., Steiniger-Brach, B. & Nielsen, J. Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to d-amphetamine: involvement of the D 1-regulated feedback control of midbrain dopamine neurons. J. Neurochem. 109, 766\u2013775 (2009).","journal-title":"J. Neurochem."},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0006-8993(85)91582-3","volume":"333","author":"AA Grace","year":"1985","unstructured":"Grace, A. A. & Bunney, B. S. Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology. Brain Res. 333, 285\u2013298 (1985).","journal-title":"Brain Res."},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1523\/JNEUROSCI.15-04-03092.1995","volume":"15","author":"JM Tepper","year":"1995","unstructured":"Tepper, J. M., Martin, L. P. & Anderson, D. R. GABAA receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons. J. Neurosci. 15, 3092\u20133103 (1995).","journal-title":"J. Neurosci."},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neulet.2010.07.014","volume":"482","author":"K Fabricius","year":"2010","unstructured":"Fabricius, K. et al. Increased dopaminergic activity in socially isolated rats: an electrophysiological study. Neurosci. Lett. 482, 117\u2013122 (2010).","journal-title":"Neurosci. Lett."},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0896-6273(03)00192-2","volume":"38","author":"RR Gainetdinov","year":"2003","unstructured":"Gainetdinov, R. R. et al. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron 38, 291\u2013303 (2003).","journal-title":"Neuron"},{"key":"11_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0306-4522(94)90465-0","volume":"62","author":"K Chergui","year":"1994","unstructured":"Chergui, K., Suaud-Chagny, M. F. & Gonon, F. Nonlinear relationship between impulse flow, dopamine release and dopamine elimination in the rat brain in vivo. Neuroscience 62, 641\u2013645 (1994).","journal-title":"Neuroscience"},{"key":"11_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0165-0270(01)00459-9","volume":"112","author":"Q Wu","year":"2001","unstructured":"Wu, Q., Reith, M. E. A., Wightman, R. M., Kawagoe, K. T. & Garris, P. A. Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J. Neurosci. Methods 112, 119\u2013133 (2001).","journal-title":"J. Neurosci. Methods"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"9134","DOI":"10.1523\/JNEUROSCI.21-23-09134.2001","volume":"21","author":"M Benoit-Marand","year":"2001","unstructured":"Benoit-Marand, M., Borrelli, E. & Gonon, F. Inhibition of dopamine release via pre-synaptic D2 receptors: time course and functional characteristics in vivo. J. Neurosci. 21, 9134\u20139141 (2001).","journal-title":"J. Neurosci."},{"key":"11_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/(SICI)1098-2396(200002)35:2<111::AID-SYN3>3.0.CO;2-7","volume":"35","author":"WX Shi","year":"2000","unstructured":"Shi, W.-X., Pun, C. L., Smith, P. L. & Bunney, B. S. Endogenous dopamine-mediated feedback inhibition of dopamine neurons: involvement of both D(1)- and D(2)-like receptors. Synapse 35, 111\u2013119 (2000).","journal-title":"Synapse"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1523\/JNEUROSCI.17-20-07988.1997","volume":"17","author":"WX Shi","year":"1997","unstructured":"Shi, W. X., Smith, P. L., Pun, C. L., Millet, B. & Bunney, B. S. D1-D2 interaction in feedback control of midbrain dopamine neurons. J. Neurosci. 17, 7988\u20137994 (1997).","journal-title":"J. Neurosci."},{"key":"11_CR30","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nn1103","volume":"6","author":"SB Floresco","year":"2003","unstructured":"Floresco, S. B., West, A. R., Ash, B., Moore, H. & Grace, A. A. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat. Neurosci. 6, 968\u2013973 (2003).","journal-title":"Nat. Neurosci."},{"key":"11_CR31","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1124\/jpet.108.146944","volume":"328","author":"F Sotty","year":"2009","unstructured":"Sotty, F. et al. Antipsychotic-like effect of retigabine [N-(2-amino-4- (fluorobenzylamino)-phenyl)carbamic acid ester], a KCNQ potassium channel opener, via modulation of mesolimbic dopaminergic neurotransmission. J. Pharmacol. Exp. Ther. 328, 951\u2013962 (2009).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"11_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/syn.890030105","volume":"3","author":"MD Kelland","year":"1989","unstructured":"Kelland, M. D., Freeman, A. S. & Chiodo, L. A. Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration. Synapse 3, 30\u201337 (1989).","journal-title":"Synapse"},{"key":"11_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(92)91498-4","volume":"597","author":"ME Hamilton","year":"1992","unstructured":"Hamilton, M. E., Mele, A. & Pert, A. Striatal extracellular dopamine in conscious vs. anesthetized rats: effects of chloral hydrate anesthetic on responses to drugs of different classes. Brain Res. 597, 1\u20137 (1992).","journal-title":"Brain Res."},{"key":"11_CR34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.biopsych.2013.08.014","volume":"76","author":"K Fejgin","year":"2014","unstructured":"Fejgin, K. et al. A mouse model that recapitulates cardinal features of the 15q13.3 microdeletion syndrome including schizophrenia- and epilepsy-related alterations. Biol. Psychiatry 76, 128\u2013137 (2014).","journal-title":"Biol. Psychiatry"},{"key":"11_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.70","volume":"2","author":"S Kimoto","year":"2012","unstructured":"Kimoto, S. et al. Selective overexpression of Comt in prefrontal cortex rescues schizophrenia-like phenotypes in a mouse model of 22q11 deletion syndrome. Transl. Psychiatry 2, e146 (2012).","journal-title":"Transl. Psychiatry"},{"key":"11_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1503\/jpn.150381","volume":"42","author":"M Didriksen","year":"2017","unstructured":"Didriksen, M. et al. Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 micro-deletion syndrome. J. Psychiatry Neurosci. 42, 48\u201358 (2017).","journal-title":"J. Psychiatry Neurosci."},{"key":"11_CR37","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/mp.2013.92","volume":"18","author":"N Hiroi","year":"2013","unstructured":"Hiroi, N., Takahashi, T., Hishimoto, A., Izumi, T., Boku, S. & Hiramoto, T. Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders. Mol. Psychiatry 18, 1153\u20131165 (2013).","journal-title":"Mol. Psychiatry"},{"key":"11_CR38","doi-asserted-by":"crossref","first-page":"472","DOI":"10.55782\/ane-2013-1953","volume":"73","author":"P Ratajczak","year":"2013","unstructured":"Ratajczak, P., Wo\u017aniak, A. & Nowakowska, E. Animal models of schizophrenia: developmental preparation in rats. Acta. Neurobiol. Exp. 73, 472\u2013484 (2013).","journal-title":"Acta. Neurobiol. Exp."},{"key":"11_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.biopsych.2006.01.003","volume":"60","author":"H Moore","year":"2006","unstructured":"Moore, H., Jentsch, J. D., Ghajarnia, M., Geyer, M. A. & Grace, A. A. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on e17: implications for the neuropathology of schizophrenia. Biol. Psychiatry 60, 253\u2013264 (2006).","journal-title":"Biol. Psychiatry"},{"key":"11_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.tins.2014.12.005","volume":"38","author":"G Modinos","year":"2015","unstructured":"Modinos, G., Allen, P., Grace, A. A. & McGuire, P. Translating the MAM model of psychosis to humans. Trends Neurosci. 38, 129\u2013138 (2015).","journal-title":"Trends Neurosci."},{"key":"11_CR41","doi-asserted-by":"publisher","first-page":"11424","DOI":"10.1523\/JNEUROSCI.2847-07.2007","volume":"27","author":"DJ Lodge","year":"2007","unstructured":"Lodge, D. J. & Grace, Aa. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J. Neurosci. 27, 11424\u201311430 (2007).","journal-title":"J. Neurosci."},{"key":"11_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/BF03033801","volume":"14","author":"DJ Lodge","year":"2008","unstructured":"Lodge, D. J. & Grace, A. A. Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia. Neurotox. Res. 14, 97\u2013104 (2008).","journal-title":"Neurotox. Res."},{"key":"11_CR43","doi-asserted-by":"publisher","first-page":"37198","DOI":"10.1074\/jbc.M110.102434","volume":"285","author":"GR Steinberg","year":"2010","unstructured":"Steinberg, G. R. et al. Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity. J. Biol. Chem. 285, 37198\u201337209 (2010).","journal-title":"J. Biol. Chem."},{"key":"11_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bcp.2015.05.013","volume":"96","author":"SG Gonzalez Malagon","year":"2015","unstructured":"Gonzalez Malagon, S. G. et al. The phenotype of a knockout mouse identifies flavin-containing monooxygenase 5 (FMO5) as a regulator of metabolic ageing. Biochem. Pharmacol. 96, 267\u2013277 (2015).","journal-title":"Biochem. Pharmacol."},{"key":"11_CR45","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0960-9822(98)70113-7","volume":"8","author":"AM Simon","year":"1998","unstructured":"Simon, A. M., Goodenough, D. A. & Paul, D. L. Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr. Biol. 8, 295\u2013298 (1998).","journal-title":"Curr. Biol."},{"key":"11_CR46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1242\/dev.129.1.167","volume":"129","author":"P Rong","year":"2002","unstructured":"Rong, P. et al. Disruption of Gja8 (alpha8 connexin) in mice leads to microphthalmia associated with retardation of lens growth and lens fiber maturation. Development 129, 167\u2013174 (2002).","journal-title":"Development"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-017-0011-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-017-0011-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-017-0011-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T06:04:01Z","timestamp":1719641041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-017-0011-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,30]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1038\/s41398-017-0011-8","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,30]]},"assertion":[{"value":"4 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.N., K.F., F.S., V.N., A.M., C.T.C., J.B.L., D.C., P.H.L., J.E., P.K., K.V.C., and M.D. are employees of Lundbeck A\/S. The remaining authors declare that they have no competing financial interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1261"}}